Abstract
Background: Obesity, metabolic syndrome, and type 2 diabetes are major public health challenges. Recently, interest has surged regarding the possible role of the intestinal microbiota as potential novel contributors to the increased prevalence of these 3 disorders. Content: Recent advances in microbial DNA sequencing technologies have resulted in the widespread application of whole-genome sequencing technologies for metagenomic DNA analysis of complex ecosystems such as the human gut. Current evidence suggests that the gut microbiota affect nutrient acquisition, energy harvest, and a myriad of host metabolic pathways. Conclusion: Advances in the Human Microbiome Project and human metagenomics research will lead the way toward a greater understanding of the importance and role of the gut microbiome in metabolic disorders such as obesity, metabolic syndrome, and diabetes.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 617-628 |
| Number of pages | 12 |
| Journal | Clinical Chemistry |
| Volume | 59 |
| Issue number | 4 |
| DOIs | |
| State | Published - Apr 2013 |
ASJC Scopus subject areas
- Clinical Biochemistry
- Biochemistry, medical
Fingerprint
Dive into the research topics of 'The human gut microbiome and body metabolism: Implications for obesity and diabetes'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS